Chronic Inflammatory Demyelinating Polyneuropathy Drug
Chronic Inflammatory Demyelinating Polyneuropathy Drug market is segmented by region (country), p ... Read More
1 Study Coverage 1.1 Metabotropic Glutamate Receptor 2 Product Introduction 1.2 Global Metabotropic Glutamate Receptor 2 Outlook 2017 VS 2022 VS 2028 1.2.1 Global Metabotropic Glutamate Receptor 2 Sales in US$ Million for the Year 2017-2028 1.2.2 Global Metabotropic Glutamate Receptor 2 Sales in Volume for the Year 2017-2028 1.3 United States Metabotropic Glutamate Receptor 2 Outlook 2017 VS 2022 VS 2028 1.3.1 United States Metabotropic Glutamate Receptor 2 Sales in US$ Million for the Year 2017-2028 1.3.2 United States Metabotropic Glutamate Receptor 2 Sales in Volume for the Year 2017-2028 1.4 Metabotropic Glutamate Receptor 2 Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Metabotropic Glutamate Receptor 2 in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Metabotropic Glutamate Receptor 2 Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Metabotropic Glutamate Receptor 2 Market Dynamics 1.5.1 Metabotropic Glutamate Receptor 2 Industry Trends 1.5.2 Metabotropic Glutamate Receptor 2 Market Drivers 1.5.3 Metabotropic Glutamate Receptor 2 Market Challenges 1.5.4 Metabotropic Glutamate Receptor 2 Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Metabotropic Glutamate Receptor 2 Market Segment by Type 2.1.1 LY-2607540 2.1.2 BMT-133218 2.1.3 DT-2442 2.1.4 JNJ-40411813 2.1.5 Others 2.2 Global Metabotropic Glutamate Receptor 2 Market Size by Type 2.2.1 Global Metabotropic Glutamate Receptor 2 Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Metabotropic Glutamate Receptor 2 Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Metabotropic Glutamate Receptor 2 Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Metabotropic Glutamate Receptor 2 Market Size by Type 2.3.1 United States Metabotropic Glutamate Receptor 2 Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Metabotropic Glutamate Receptor 2 Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Metabotropic Glutamate Receptor 2 Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Metabotropic Glutamate Receptor 2 Market Segment by Application 3.1.1 Anxiety Disorders 3.1.2 Depression 3.1.3 Schizophrenia 3.1.4 Chronic Pain 3.1.5 Others 3.2 Global Metabotropic Glutamate Receptor 2 Market Size by Application 3.2.1 Global Metabotropic Glutamate Receptor 2 Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Metabotropic Glutamate Receptor 2 Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Metabotropic Glutamate Receptor 2 Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Metabotropic Glutamate Receptor 2 Market Size by Application 3.3.1 United States Metabotropic Glutamate Receptor 2 Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Metabotropic Glutamate Receptor 2 Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Metabotropic Glutamate Receptor 2 Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Metabotropic Glutamate Receptor 2 Competitor Landscape by Company 4.1 Global Metabotropic Glutamate Receptor 2 Market Size by Company 4.1.1 Top Global Metabotropic Glutamate Receptor 2 Manufacturers Ranked by Revenue (2021) 4.1.2 Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturer (2017-2022) 4.1.3 Global Metabotropic Glutamate Receptor 2 Sales by Manufacturer (2017-2022) 4.1.4 Global Metabotropic Glutamate Receptor 2 Price by Manufacturer (2017-2022) 4.2 Global Metabotropic Glutamate Receptor 2 Concentration Ratio (CR) 4.2.1 Metabotropic Glutamate Receptor 2 Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Metabotropic Glutamate Receptor 2 in 2021 4.2.3 Global Metabotropic Glutamate Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Metabotropic Glutamate Receptor 2 Manufacturing Base Distribution, Product Type 4.3.1 Global Metabotropic Glutamate Receptor 2 Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Metabotropic Glutamate Receptor 2 Product Type 4.3.3 Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 2 Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Metabotropic Glutamate Receptor 2 Market Size by Company 4.5.1 Top Metabotropic Glutamate Receptor 2 Players in United States, Ranked by Revenue (2021) 4.5.2 United States Metabotropic Glutamate Receptor 2 Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Metabotropic Glutamate Receptor 2 Sales by Players (2020, 2021 & 2022) 5 Global Metabotropic Glutamate Receptor 2 Market Size by Region 5.1 Global Metabotropic Glutamate Receptor 2 Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Metabotropic Glutamate Receptor 2 Market Size in Volume by Region (2017-2028) 5.2.1 Global Metabotropic Glutamate Receptor 2 Sales in Volume by Region: 2017-2022 5.2.2 Global Metabotropic Glutamate Receptor 2 Sales in Volume Forecast by Region (2023-2028) 5.3 Global Metabotropic Glutamate Receptor 2 Market Size in Value by Region (2017-2028) 5.3.1 Global Metabotropic Glutamate Receptor 2 Sales in Value by Region: 2017-2022 5.3.2 Global Metabotropic Glutamate Receptor 2 Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Metabotropic Glutamate Receptor 2 Market Size YoY Growth 2017-2028 6.1.2 North America Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Metabotropic Glutamate Receptor 2 Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Metabotropic Glutamate Receptor 2 Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Metabotropic Glutamate Receptor 2 Market Size YoY Growth 2017-2028 6.3.2 Europe Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Metabotropic Glutamate Receptor 2 Market Size YoY Growth 2017-2028 6.4.2 Latin America Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Metabotropic Glutamate Receptor 2 Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Addex Therapeutics Ltd 7.1.1 Addex Therapeutics Ltd Corporation Information 7.1.2 Addex Therapeutics Ltd Description and Business Overview 7.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Products Offered 7.1.5 Addex Therapeutics Ltd Recent Development 7.2 Bristol-Myers Squibb Company 7.2.1 Bristol-Myers Squibb Company Corporation Information 7.2.2 Bristol-Myers Squibb Company Description and Business Overview 7.2.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Products Offered 7.2.5 Bristol-Myers Squibb Company Recent Development 7.3 Denovo Biopharma LLC 7.3.1 Denovo Biopharma LLC Corporation Information 7.3.2 Denovo Biopharma LLC Description and Business Overview 7.3.3 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Products Offered 7.3.5 Denovo Biopharma LLC Recent Development 7.4 Domain Therapeutics SA 7.4.1 Domain Therapeutics SA Corporation Information 7.4.2 Domain Therapeutics SA Description and Business Overview 7.4.3 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Products Offered 7.4.5 Domain Therapeutics SA Recent Development 7.5 Eli Lilly and Company 7.5.1 Eli Lilly and Company Corporation Information 7.5.2 Eli Lilly and Company Description and Business Overview 7.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2017-2022) 7.5.4 Eli Lilly and Company Metabotropic Glutamate Receptor 2 Products Offered 7.5.5 Eli Lilly and Company Recent Development 7.6 Johnson & Johnson 7.6.1 Johnson & Johnson Corporation Information 7.6.2 Johnson & Johnson Description and Business Overview 7.6.3 Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Johnson & Johnson Metabotropic Glutamate Receptor 2 Products Offered 7.6.5 Johnson & Johnson Recent Development 7.7 Merck & Co Inc 7.7.1 Merck & Co Inc Corporation Information 7.7.2 Merck & Co Inc Description and Business Overview 7.7.3 Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales, Revenue and Gross Margin (2017-2022) 7.7.4 Merck & Co Inc Metabotropic Glutamate Receptor 2 Products Offered 7.7.5 Merck & Co Inc Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Metabotropic Glutamate Receptor 2 Industry Chain Analysis 8.2 Metabotropic Glutamate Receptor 2 Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Metabotropic Glutamate Receptor 2 Distributors 8.3 Metabotropic Glutamate Receptor 2 Production Mode & Process 8.4 Metabotropic Glutamate Receptor 2 Sales and Marketing 8.4.1 Metabotropic Glutamate Receptor 2 Sales Channels 8.4.2 Metabotropic Glutamate Receptor 2 Distributors 8.5 Metabotropic Glutamate Receptor 2 Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
List of Tables Table 1. Metabotropic Glutamate Receptor 2 CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Metabotropic Glutamate Receptor 2 Market Trends Table 3. Metabotropic Glutamate Receptor 2 Market Drivers Table 4. Metabotropic Glutamate Receptor 2 Market Challenges Table 5. Metabotropic Glutamate Receptor 2 Market Restraints Table 6. Global Metabotropic Glutamate Receptor 2 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Metabotropic Glutamate Receptor 2 Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Metabotropic Glutamate Receptor 2 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Metabotropic Glutamate Receptor 2 Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Metabotropic Glutamate Receptor 2 Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Metabotropic Glutamate Receptor 2 Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Metabotropic Glutamate Receptor 2 Revenue Share by Manufacturer, 2017-2022 Table 13. Global Metabotropic Glutamate Receptor 2 Sales by Manufacturer, (K Pcs), 2017-2022 Table 14. Global Metabotropic Glutamate Receptor 2 Sales Share by Manufacturer, 2017-2022 Table 15. Global Metabotropic Glutamate Receptor 2 Price by Manufacturer (2017-2022) & (USD/Pcs) Table 16. Global Metabotropic Glutamate Receptor 2 Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Metabotropic Glutamate Receptor 2 by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabotropic Glutamate Receptor 2 as of 2021) Table 18. Top Players of Metabotropic Glutamate Receptor 2 in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Metabotropic Glutamate Receptor 2 Product Type Table 20. Date of International Manufacturers Enter into Metabotropic Glutamate Receptor 2 Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Metabotropic Glutamate Receptor 2 Players in United States Market, Ranking by Revenue (2021) Table 23. United States Metabotropic Glutamate Receptor 2 Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Metabotropic Glutamate Receptor 2 Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Metabotropic Glutamate Receptor 2 Sales by Players, (K Pcs), 2020, 2021 & 2022 Table 26. United States Metabotropic Glutamate Receptor 2 Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Metabotropic Glutamate Receptor 2 Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2017-2022) & (K Pcs) Table 29. Global Metabotropic Glutamate Receptor 2 Sales in Volume Forecast by Region (2023-2028) & (K Pcs) Table 30. Global Metabotropic Glutamate Receptor 2 Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Metabotropic Glutamate Receptor 2 Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028) & (K Pcs) Table 33. North America Metabotropic Glutamate Receptor 2 Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Metabotropic Glutamate Receptor 2 Sales in Volume by Region (2017-2028) & (K Pcs) Table 35. Asia Pacific Metabotropic Glutamate Receptor 2 Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028) & (K Pcs) Table 37. Europe Metabotropic Glutamate Receptor 2 Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028) & (K Pcs) Table 39. Latin Americaa Metabotropic Glutamate Receptor 2 Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales in Volume by Country (2017-2028) & (K Pcs) Table 41. Middle East and Africa Metabotropic Glutamate Receptor 2 Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Addex Therapeutics Ltd Corporation Information Table 43. Addex Therapeutics Ltd Description and Business Overview Table 44. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 45. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 2 Product Table 46. Addex Therapeutics Ltd Recent Development Table 47. Bristol-Myers Squibb Company Corporation Information Table 48. Bristol-Myers Squibb Company Description and Business Overview Table 49. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 50. Bristol-Myers Squibb Company Product Table 51. Bristol-Myers Squibb Company Recent Development Table 52. Denovo Biopharma LLC Corporation Information Table 53. Denovo Biopharma LLC Description and Business Overview Table 54. Denovo Biopharma LLC Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 55. Denovo Biopharma LLC Product Table 56. Denovo Biopharma LLC Recent Development Table 57. Domain Therapeutics SA Corporation Information Table 58. Domain Therapeutics SA Description and Business Overview Table 59. Domain Therapeutics SA Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 60. Domain Therapeutics SA Product Table 61. Domain Therapeutics SA Recent Development Table 62. Eli Lilly and Company Corporation Information Table 63. Eli Lilly and Company Description and Business Overview Table 64. Eli Lilly and Company Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 65. Eli Lilly and Company Product Table 66. Eli Lilly and Company Recent Development Table 67. Johnson & Johnson Corporation Information Table 68. Johnson & Johnson Description and Business Overview Table 69. Johnson & Johnson Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 70. Johnson & Johnson Product Table 71. Johnson & Johnson Recent Development Table 72. Merck & Co Inc Corporation Information Table 73. Merck & Co Inc Description and Business Overview Table 74. Merck & Co Inc Metabotropic Glutamate Receptor 2 Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022) Table 75. Merck & Co Inc Product Table 76. Merck & Co Inc Recent Development Table 77. Key Raw Materials Lists Table 78. Raw Materials Key Suppliers Lists Table 79. Metabotropic Glutamate Receptor 2 Customers List Table 80. Metabotropic Glutamate Receptor 2 Distributors List Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 2 Product Picture Figure 2. Global Metabotropic Glutamate Receptor 2 Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Metabotropic Glutamate Receptor 2 Market Size 2017-2028 (US$ Million) Figure 4. Global Metabotropic Glutamate Receptor 2 Sales 2017-2028 (K Pcs) Figure 5. United States Metabotropic Glutamate Receptor 2 Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Metabotropic Glutamate Receptor 2 Market Size 2017-2028 (US$ Million) Figure 7. United States Metabotropic Glutamate Receptor 2 Sales 2017-2028 (K Pcs) Figure 8. United States Metabotropic Glutamate Receptor 2 Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Metabotropic Glutamate Receptor 2 Market Share in Global, in Volume (K Pcs) 2017-2028 Figure 10. Metabotropic Glutamate Receptor 2 Report Years Considered Figure 11. Product Picture of LY-2607540 Figure 12. Product Picture of BMT-133218 Figure 13. Product Picture of DT-2442 Figure 14. Product Picture of JNJ-40411813 Figure 15. Product Picture of Others Figure 16. Global Metabotropic Glutamate Receptor 2 Market Share by Type in 2022 & 2028 Figure 17. Global Metabotropic Glutamate Receptor 2 Sales in Value by Type (2017-2028) & (US$ Million) Figure 18. Global Metabotropic Glutamate Receptor 2 Sales Market Share in Value by Type (2017-2028) Figure 19. Global Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028) & (K Pcs) Figure 20. Global Metabotropic Glutamate Receptor 2 Sales Market Share in Volume by Type (2017-2028) Figure 21. Global Metabotropic Glutamate Receptor 2 Price by Type (2017-2028) & (USD/Pcs) Figure 22. United States Metabotropic Glutamate Receptor 2 Market Share by Type in 2022 & 2028 Figure 23. United States Metabotropic Glutamate Receptor 2 Sales in Value by Type (2017-2028) & (US$ Million) Figure 24. United States Metabotropic Glutamate Receptor 2 Sales Market Share in Value by Type (2017-2028) Figure 25. United States Metabotropic Glutamate Receptor 2 Sales by Type (2017-2028) & (K Pcs) Figure 26. United States Metabotropic Glutamate Receptor 2 Sales Market Share in Volume by Type (2017-2028) Figure 27. United States Metabotropic Glutamate Receptor 2 Price by Type (2017-2028) & (USD/Pcs) Figure 28. Product Picture of Anxiety Disorders Figure 29. Product Picture of Depression Figure 30. Product Picture of Schizophrenia Figure 31. Product Picture of Chronic Pain Figure 32. Product Picture of Others Figure 33. Global Metabotropic Glutamate Receptor 2 Market Share by Application in 2022 & 2028 Figure 34. Global Metabotropic Glutamate Receptor 2 Sales in Value by Application (2017-2028) & (US$ Million) Figure 35. Global Metabotropic Glutamate Receptor 2 Sales Market Share in Value by Application (2017-2028) Figure 36. Global Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028) & (K Pcs) Figure 37. Global Metabotropic Glutamate Receptor 2 Sales Market Share in Volume by Application (2017-2028) Figure 38. Global Metabotropic Glutamate Receptor 2 Price by Application (2017-2028) & (USD/Pcs) Figure 39. United States Metabotropic Glutamate Receptor 2 Market Share by Application in 2022 & 2028 Figure 40. United States Metabotropic Glutamate Receptor 2 Sales in Value by Application (2017-2028) & (US$ Million) Figure 41. United States Metabotropic Glutamate Receptor 2 Sales Market Share in Value by Application (2017-2028) Figure 42. United States Metabotropic Glutamate Receptor 2 Sales by Application (2017-2028) & (K Pcs) Figure 43. United States Metabotropic Glutamate Receptor 2 Sales Market Share in Volume by Application (2017-2028) Figure 44. United States Metabotropic Glutamate Receptor 2 Price by Application (2017-2028) & (USD/Pcs) Figure 45. North America Metabotropic Glutamate Receptor 2 Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 46. North America Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. U.S. Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. Canada Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Europe Metabotropic Glutamate Receptor 2 Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 50. Europe Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 51. Germany Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. France Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 53. U.K. Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Italy Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Russia Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 57. Asia-Pacific Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 58. China Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Japan Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. South Korea Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. India Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Australia Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Taiwan Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Indonesia Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 65. Thailand Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Malaysia Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Philippines Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Latin America Metabotropic Glutamate Receptor 2 Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 69. Latin America Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Mexico Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Brazil Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Argentina Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales in Volume Growth Rate 2017-2028 (K Pcs) Figure 74. Middle East & Africa Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 75. Turkey Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 76. Saudi Arabia Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 77. U.A.E Metabotropic Glutamate Receptor 2 Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 78. Metabotropic Glutamate Receptor 2 Value Chain Figure 79. Metabotropic Glutamate Receptor 2 Production Process Figure 80. Channels of Distribution Figure 81. Distributors Profiles Figure 82. Bottom-up and Top-down Approaches for This Report Figure 83. Data Triangulation Figure 84. Key Executives Interviewed
Addex Therapeutics Ltd Bristol-Myers Squibb Company Denovo Biopharma LLC Domain Therapeutics SA Eli Lilly and Company Johnson & Johnson Merck & Co Inc
Chronic Inflammatory Demyelinating Polyneuropathy Drug market is segmented by region (country), p ... Read More
Trigeminal Neuralgia Therapeutics market is segmented by region (country), players, by Type and b ... Read More
Visceral Pain Treatment market is segmented by region (country), players, by Type and by Applicat ... Read More
Hodgkin Lymphoma Treatment market is segmented by region (country), players, by Type and by Appli ... Read More